Q9PSM2 AF NFT

Pancreatic secretory trypsin inhibitor

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibg45nuzdzspdftnh5xhkystrn5vefcaqftlsc57j4whzmu3sevzq/metadata.json
IPFS of structure file: 
bafybeifykmvff22cxddjfmdexdluv57le6ltybc3ztwvdg5akd64cd3mdi/AF-Q9PSM2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xedF7E883F21b4158322726Df67739027A4E8EBB1
First NFT owner address (bech32): 
genesis1ahm73qljrdq4sv38ym0kwuusy7jw36a3zq35nu
Current NFT ID #192706 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
192706
Accession (UniProt):
Q9PSM2
Name::
Pancreatic secretory trypsin inhibitor
Experimental Method:
Predicted structure
Sequence source:
STRUTHIO CAMELUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9PSM2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9PSM2|ISK1_STRCA Pancreatic secretory trypsin inhibitor OS=Struthio camelus OX=8801 GN=SPINK1 PE=1 SV=1 EPDSAADTGTEAACSNYDLKKGCAKIFDPVCGTDNILYSNECLLCFQNLQRKTNVRIKRRGTCQEPSPR